Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs-Reference-Cited by-同舟云学术

Risk of Significant Infection in Rheumatoid Arthritis Patients Switching Anti-Tumor Necrosis Factor-α Drugs

Published:2012-10 Issue:2 Volume:42 Page:119-126
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Nguyen-Khoa Bao-Anh,Goehring Earl L.,Alexander Kimberly A.,Dong Wei,Napalkov Pavel,Jones Judith K.

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference17 articles.

1. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: A systematic review and metaanalysis;Gartlehner;J Rheumatol,2006

2. Infections in patients with rheumatoid arthritis treated with biologic agents;Listing;Arthritis Rheum,2005

3. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists;Curtis;Arthritis Rheum,2007

4. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register;Dixon;Arthritis Rheum,2006

5. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis;Schneeweiss;Arthritis Rheum,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-04

2. Incidence of severe infection in patients with rheumatoid arthritis taking biologic agents: a systematic review;JBI Evidence Synthesis;2023-01-11

3. Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USA;Rheumatology and Therapy;2022-12-26

4. Association Between the Number of Comorbidities and the Risk of a Serious Infection in Rheumatoid Arthritis Treated by a First Biologic Agent;JCR: Journal of Clinical Rheumatology;2020-12-16

5. Increased risk of opportunistic infection in early rheumatoid arthritis;International Journal of Rheumatic Diseases;2019-05-14